Target type: biologicalprocess
The disaggregation of an organelle into its constituent components. [GO_REF:0000079, GOC:TermGenie]
Organelle disassembly is a fundamental cellular process that involves the controlled breakdown and removal of cellular organelles. This process is essential for maintaining cellular homeostasis, responding to environmental changes, and facilitating developmental transitions.
Organelle disassembly can occur through various mechanisms, including:
1. **Autophagy:** A major pathway for organelle removal, where organelles are enclosed in double-membrane vesicles called autophagosomes. These autophagosomes fuse with lysosomes, where the enclosed organelles are degraded by hydrolytic enzymes.
2. **Selective degradation by the ubiquitin-proteasome system:** Certain organelles, like the endoplasmic reticulum (ER), can undergo selective degradation through the ubiquitin-proteasome system. This system targets specific proteins for degradation, leading to the dismantling of the organelle.
3. **Direct protein degradation:** Some organelles, such as the Golgi apparatus, can be disassembled by the direct degradation of their constituent proteins. This can involve the removal of individual proteins or the breakdown of entire protein complexes.
4. **Fragmentation and dispersal:** Some organelles, like mitochondria, can undergo fragmentation into smaller units. These fragments can then be degraded by autophagy or other mechanisms.
The specific mechanisms and timing of organelle disassembly vary depending on the type of organelle, the cellular context, and the environmental cues. However, the overall process is tightly regulated to ensure that the cellular environment is maintained and that the cell can respond appropriately to changing conditions.
Organelle disassembly is crucial for:
- **Cellular homeostasis:** By removing damaged or surplus organelles, disassembly helps maintain cellular integrity and function.
- **Adaptation to stress:** During stress conditions, cells can selectively degrade organelles that are no longer needed or are contributing to stress.
- **Development:** During development, organelle disassembly is essential for the remodelling of cells and tissues.
- **Cell death:** Organelle disassembly can also play a role in programmed cell death (apoptosis), ensuring a controlled and orderly process.
Organelle disassembly is a complex and tightly regulated process that is essential for cellular function and survival. Understanding the mechanisms and regulation of this process is crucial for comprehending the complexities of cellular life and for developing new therapeutic strategies for diseases involving organelle dysfunction.'
"
Protein | Definition | Taxonomy |
---|---|---|
Dual specificity tyrosine-phosphorylation-regulated kinase 3 | A dual specificity tyrosine-phosphorylation-regulated kinase 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O43781] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
staurosporine | indolocarbazole alkaloid; organic heterooctacyclic compound | apoptosis inducer; bacterial metabolite; EC 2.7.11.13 (protein kinase C) inhibitor; geroprotector | |
cyc 202 | seliciclib : 2,6-Diaminopurine carrying benzylamino, (2R)-1-hydroxybutan-2-yl and isopropyl substituents at C-6, C-2-N and N-9 respectively. It is an experimental drug candidate in the family of pharmacological cyclin-dependent kinase (CDK) inhibitors. | 2,6-diaminopurines | antiviral drug; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor |
harmine | harmine : A harmala alkaloid in which the harman skeleton is methoxy-substituted at C-7. Harmine: Alkaloid isolated from seeds of PEGANUM HARMALA; ZYGOPHYLLACEAE. It is identical to banisterine, or telepathine, from Banisteria caapi and is one of the active ingredients of hallucinogenic drinks made in the western Amazon region from related plants. It has no therapeutic use, but (as banisterine) was hailed as a cure for postencephalitic PARKINSON DISEASE in the 1920's. | harmala alkaloid | anti-HIV agent; EC 1.4.3.4 (monoamine oxidase) inhibitor; metabolite |
leucettamine b | leucettamine B: a protein kinase inhibitor isolated from the marine sponge Leucetta microraphis; structure in first source | ||
cgp 57380 | CGP 57380: inhibits the mitogen-activated protein kinase-interacting kinase Mnk1 | pyrazolopyrimidine | |
((5z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4h-imidazol-4-one) | leucettine L41 : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a (2-anilino-5-oxo-1,5-dihydro-4H-imidazol-4-ylidene)methyl group at position 5. It is an inhibitor of DYRK1A, DYRK2, CLK1, and CLK3 (IC50s = 0.04, 0.035, 0.015, and 4.5 muM, respectively). | benzodioxoles; imidazolone; substituted aniline | autophagy inducer; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor; EC 2.7.12.1 (dual-specificity kinase) inhibitor; neuroprotective agent; nootropic agent |